Fesoterodine
Fesoterodine is an oral extended-release medication used to treat overactive bladder in adults and, as Toviaz, neurogenic detrusor overactivity in children aged 6 and older.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 12 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Fesoterodine: Patient Information Guide
A plain-language walkthrough of Fesoterodine — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Fesoterodine is an extended-release oral tablet used across the following conditions:
- Overactive bladder (OAB) in adults — treats urgency (sudden, hard-to-ignore urge to urinate), frequent urination, and urge urinary incontinence (leaking caused by that sudden urge)
- Neurogenic detrusor overactivity (NDO) in children aged 6 and older weighing more than 25 kg — Toviaz (fesoterodine fumarate extended-release tablets) is specifically approved for this use; the generic fesoterodine fumarate labeling does not include pediatric NDO information due to marketing exclusivity
⚙️How it works▾
Fesoterodine is a muscarinic receptor antagonist — it blocks specific nerve receptors in the bladder wall that normally trigger muscle contractions. Once you take it orally, your body rapidly converts it into its active form (called 5-hydroxymethyl tolterodine), which is responsible for the drug's effects. By blocking those receptors, fesoterodine reduces unwanted bladder contractions, increases the amount of urine the bladder can hold before the urge kicks in, and helps you regain control over when you go.
💊How it's taken▾
Fesoterodine is taken once daily by mouth as an extended-release tablet. It can be taken with or without food — food has no clinically meaningful effect on how the drug works. The tablet must be swallowed whole; do not chew, crush, or split it, as this would destroy the extended-release design.
- Dose adjustments may be needed for adults with kidney impairment
- Adults taking strong CYP3A4 inhibitors (like ketoconazole or clarithromycin) should not exceed the lower dose — your prescriber will guide this
- For pediatric NDO patients, dosing is based on body weight and may be titrated over time under medical supervision
Always follow your prescriber's exact instructions, and don't adjust your dose on your own.
🤒Side effects — in detail▾
The most common side effects of fesoterodine are related to its anticholinergic (nerve-blocking) action:
- Dry mouth — the most frequently reported; more common at higher doses
- Constipation
- Dry eyes
- Urinary tract infection (UTI)
- Difficult or painful urination (dysuria)
- Upset stomach or indigestion (dyspepsia)
- Nausea
- Headache, dizziness, or drowsiness
- Increased heart rate — mild increases have been seen in both adults and children
- In children treated for NDO: diarrhea, abdominal pain, and weight gain were also reported, along with some vision-related effects (blurred vision, accommodation difficulty)
Stop the medication and get emergency help if you develop swelling of the face, lips, tongue, or throat (angioedema), or if you suddenly cannot urinate at all — these require immediate medical attention.
⚠️Warnings & precautions▾
- Angioedema (serious swelling): Swelling of the face, lips, tongue, or throat has occurred — sometimes after just the first dose. This can block your airway and become life-threatening. Stop fesoterodine immediately and seek emergency care if this happens.
- Urinary retention: Fesoterodine is not recommended for people with significant bladder outlet blockage and is contraindicated in those who already cannot urinate. It can make retention worse and potentially injure the kidneys.
- Slowed gut function: The medication can slow bowel movement. It is contraindicated in gastric retention and not recommended in people with severe constipation.
- Narrow-angle glaucoma: Fesoterodine can worsen this eye condition. It is contraindicated in uncontrolled narrow-angle glaucoma and should be used with caution in controlled cases.
- Drowsiness and CNS effects: Headache, dizziness, and somnolence (sleepiness) can occur. Do not drive or use heavy machinery until you know how this drug affects you.
- Myasthenia gravis: Use with caution — fesoterodine may worsen muscle weakness in people with this condition.
- Heart rate increases in children: Meaningful increases in heart rate were observed in pediatric NDO patients, especially younger children on higher doses. Heart rate should be monitored.
🔀What it interacts with▾
Fesoterodine can interact with several drugs and substances — always share your full medication list with your prescriber and pharmacist:
- Other anticholinergic/antimuscarinic drugs — combining them amplifies side effects like dry mouth, constipation, and urinary retention
- Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin) — nearly double the amount of active drug in your blood; doses above the lower level are not recommended in adults taking these, and pediatric dosing must also be reduced or the drug avoided
- Moderate CYP3A4 inhibitors (erythromycin, fluconazole, diltiazem, verapamil, grapefruit juice) — cause a modest increase in drug levels; no dose adjustment required, but worth flagging to your pharmacist
- CYP3A4 inducers (rifampin, carbamazepine) — can reduce fesoterodine levels by about 70–75%, potentially making it less effective; no dose adjustment is currently recommended, but your prescriber should be aware
- Warfarin — no meaningful interaction found in studies, but continue standard INR monitoring as usual
- Oral contraceptives — no clinically significant changes in hormone levels were seen
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not take if you have urinary retention, gastric (stomach) retention, uncontrolled narrow-angle glaucoma, or a known allergy to fesoterodine or tolterodine
- Tell your doctor if you have any bladder outlet obstruction or difficulty emptying your bladder
- Tell your doctor if you have narrow-angle glaucoma that is being treated — the medication can still be used with caution
- Tell your doctor if you have severe constipation or very slow gut movement
- Tell your doctor if you have myasthenia gravis — fesoterodine may worsen muscle weakness
- Kidney impairment: Dose adjustments are needed in adults with reduced kidney function — your prescriber will determine the right amount
- Pregnancy: No human safety data exist. Animal studies showed fetal effects at high doses. Discuss risks and benefits honestly with your doctor
- Breastfeeding: It is not known whether fesoterodine passes into breast milk. Discuss with your doctor before using
- Older adults (especially 75+): More likely to experience anticholinergic side effects including dry mouth, constipation, dizziness, and UTIs — use with extra monitoring
- Children under 6, or weighing 25 kg or less: Safety and effectiveness have not been established
🚑If you take too much▾
Taking too much fesoterodine can cause severe anticholinergic effects — think extreme dry mouth, inability to urinate, rapid heart rate, confusion, or blurred vision. Treatment focuses on managing these symptoms and supporting the body. An ECG (heart tracing) is recommended to monitor heart rhythm after an overdose — if you suspect an overdose, seek emergency medical help immediately.
📡Pharmacodynamics — effects in the body▾
Fesoterodine works directly on the bladder: in clinical studies, it increased both the volume of urine needed to trigger the first bladder contraction and the overall bladder capacity, in a dose-related way. It does not appear to affect the heart's electrical rhythm (QT interval) at therapeutic or even high doses, though it does modestly raise heart rate — by a few beats per minute at typical doses in adults, and somewhat more in children at higher doses.
🔬Pharmacokinetics — how your body processes it▾
After you swallow fesoterodine, it is rapidly converted by enzymes in your body into its active form — fesoterodine itself is never actually detected in the bloodstream. The active form reaches peak blood levels in about 5 hours and has a half-life (the time for half of it to leave your body) of roughly 7 hours after oral dosing. It is processed mainly by the liver (via the CYP2D6 and CYP3A4 enzyme pathways) and cleared primarily through urine. About 7% of people process CYP2D6 more slowly, which roughly doubles the amount of active drug in their system — an important reason your prescriber may adjust your dose based on other medications you take.
📦How to store it▾
Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) . Protect from moisture.
📄 Written from Fesoterodine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Fesoterodine
195 supplements and herbal products have documented interactions with Fesoterodine in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 9
- Moderate · 147
- Minor · 39
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Fesoterodine — the kind of thing our pharmacy team would talk through with you at the counter.
What is fesoterodine actually doing for my bladder? ▾
Do I have to take it with food? ▾
Dry mouth seems really common — is there anything I can do about it? ▾
What side effects should make me call my doctor right away? ▾
I take other medications — are there any I need to watch out for? ▾
Is it safe to drive while taking this? ▾
Is Fesoterodine available over the counter? ▾
When was Fesoterodine first available? ▾
Who makes Fesoterodine? ▾
💬 Answers drafted from Fesoterodine’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Fesoterodine comes
Fesoterodine is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Extended-release tablet
How this form is used
- Treats overactive bladder (OAB) in adults with urgency, frequent urination, and urge urinary incontinence
- Toviaz is approved to treat neurogenic detrusor overactivity (NDO) in children aged 6 and older weighing more than 25 kg
- Swallow the tablet whole with liquid — do not chew, crush, or divide it
- Take once daily, with or without food
- If you take a strong CYP3A4 inhibitor (such as ketoconazole or clarithromycin), your prescriber may limit your dose
- Follow your prescriber's guidance on dose — adjustments may be needed based on kidney function or other medications
📊 Fesoterodine across the U.S. market
How Fesoterodine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (8) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Fesoterodine is used
A general measure of how commonly Fesoterodine is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Fesoterodine is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Fesoterodine prescribed? Of the 1,596 medications we measure, Fesoterodine ranks #768 by Medicaid prescriptions — more than 52% of them.
Utilization by Fesoterodine product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet Most dispensed
Summed across the 8 of 34 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 810077
24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet
Summed across the 8 of 33 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 810071
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Fesoterodine, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 16 of 67 listed Fesoterodine NDCs with Medicaid activity.
🔍 Compare Fesoterodine products
A representative set of FDA-listed product records for Fesoterodine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release tablet | ||||
| 4 mg | — | Aesica Pharmaceuticals GmbH | DRUG FOR FURTHER PROCESSING | View NDC → |
| 8 mg | — | Aesica Pharmaceuticals GmbH | DRUG FOR FURTHER PROCESSING | View NDC → |
| 4 mg | Oral | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 8 mg | Oral | Alembic Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 8 mg | Oral | Alembic Pharmaceuticals Limited | ANDA | View NDC → |
| 4 mg | Oral | Amneal Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| 8 mg | Oral | Amneal Pharmaceuticals LLC × 2 listings | ANDA | View NDC → |
| 8 mg | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Ascend Laboratories, LLC × 3 listings | ANDA | View NDC → |
| 8 mg | Oral | Ascend Laboratories, LLC × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 8 mg | Oral | Aurobindo Pharma Limited × 3 listings | ANDA | View NDC → |
| 4 mg | Oral | AvKARE | ANDA | View NDC → |
| 8 mg | Oral | AvKARE | ANDA | View NDC → |
| 4 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 8 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 4 mg | Oral | Dr.Reddy's Laboratories Inc., × 2 listings | ANDA | View NDC → |
| 8 mg | Oral | Dr.Reddy's Laboratories Inc., × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 8 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 8 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 4 mg | Oral | Pfizer Laboratories Div Pfizer Inc × 3 listings | NDA | View NDC → |
| 8 mg | Oral | Pfizer Laboratories Div Pfizer Inc × 3 listings | NDA | View NDC → |
| 4 mg | Oral | U.S. Pharmaceuticals × 2 listings | NDA | View NDC → |
| 8 mg | Oral | U.S. Pharmaceuticals × 2 listings | NDA | View NDC → |
| 4 mg | Oral | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 8 mg | Oral | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 4 mg | Oral | Zydus Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 8 mg | Oral | Zydus Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Amino Chemicals Ltd × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Hetero Drugs Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Maithri Laboratories Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | MSN Pharmachem Private Limited × 2 listings | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Pfizer Ireland Pharmaceuticals Unlimited Company | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Raks Pharma Pvt. Limited | BULK INGREDIENT | View NDC → |
Showing 65 of 65 products — FDA National Drug Code Directory. See every product, package size and price: browse all 65 Fesoterodine NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Fesoterodine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Fesoterodine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Fesoterodine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 797195 1 dose form · 2 strengths
-
Dose form (SCDF) Extended Release Oral Tablet RxCUI 810070In current FDA listingsClinical drug / strength (SCD) 24 HR fesoterodine fumarate 4 MGRxCUI 81007124 HR fesoterodine fumarate 8 MGRxCUI 810077
Look up RxCUI 797195 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Fesoterodine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Fesoterodine belongs to the Drugs for urinary frequency and incontinence class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 12 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Pfizer Laboratories Div Pfizer Inc is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.